These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 2377285)

  • 1. Multiparameter flow cytometric analysis of neoplasms of the central nervous system: correlation of nuclear antigen p105 and DNA content with clinical behavior.
    Appley AJ; Fitzgibbons PL; Chandrasoma PT; Hinton DR; Apuzzo ML
    Neurosurgery; 1990 Jul; 27(1):83-96. PubMed ID: 2377285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flow cytometric DNA ploidy and cells phase fractions in recurrent human pituitary adenomas. A correlative study of flow cytometric analysis and the expression of proliferating cell nuclear antigen.
    Chae YS; Flotte T; Hsu DW; Preffer F; Hedley-Whyte ET
    Gen Diagn Pathol; 1996 Oct; 142(2):89-95. PubMed ID: 8950573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flow cytometric analysis of pituitary tumors. Correlation of nuclear antigen p105 and DNA content with clinical behavior.
    Fitzgibbons PL; Appley AJ; Turner RR; Bishop PC; Parker JW; Breeze RE; Weiss MH; Apuzzo ML
    Cancer; 1988 Oct; 62(8):1556-60. PubMed ID: 3048631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flow cytometric DNA and nuclear antigen content in astrocytic neoplasms.
    Fitzgibbons PL; Turner RR; Appley AJ; Bishop PC; Nichols PW; Epstein AL; Apuzzo ML; Chandrasoma PT
    Am J Clin Pathol; 1988 May; 89(5):640-4. PubMed ID: 2895977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flow cytometric quantitation of the proliferation-associated nuclear antigen p105 and DNA content in patients with renal cell carcinoma.
    Yokogi H
    Cancer; 1996 Aug; 78(4):819-26. PubMed ID: 8756377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic significance of MIB-1, p53, and DNA flow cytometry in completely resected primary meningiomas.
    Perry A; Stafford SL; Scheithauer BW; Suman VJ; Lohse CM
    Cancer; 1998 Jun; 82(11):2262-9. PubMed ID: 9610708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flow cytometric measurements of proliferation-associated nuclear antigen p105 and DNA content in non-Hodgkin's lymphomas.
    Turner RR; Layfield LJ; Bishop PC; Epstein AL; Parker JW
    Arch Pathol Lab Med; 1989 Aug; 113(8):907-11. PubMed ID: 2569301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous nuclear antigen and DNA content quantitation using paraffin-embedded colonic tissue and multiparameter flow cytometry.
    Bauer KD; Clevenger CV; Endow RK; Murad T; Epstein AL; Scarpelli DG
    Cancer Res; 1986 May; 46(5):2428-34. PubMed ID: 3516382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA content in renal cell carcinoma. A clinical study with special reference to tumor heterogeneity and prognosis.
    Ljungberg B
    Scand J Urol Nephrol Suppl; 1986; 100():1-47. PubMed ID: 3472340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flow cytometric quantification of the proliferation-associated nuclear antigen p105 and DNA content in advanced head & neck cancers: results of RTOG 91-08.
    Fu KK; Hammond E; Pajak TF; Clery M; Doggett RL; Byhardt RW; McDonald S; Cooper JS
    Int J Radiat Oncol Biol Phys; 1994 Jul; 29(4):661-71. PubMed ID: 7913703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA content and chromosomal composition of malignant human gliomas.
    Bigner SH; Bjerkvig R; Laerum OD
    Neurol Clin; 1985 Nov; 3(4):769-84. PubMed ID: 3001489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Smooth muscle tumors of the gastrointestinal tract. Flow cytometric quantitation of DNA and nuclear antigen content and correlation with histologic grade.
    Kiyabu MT; Bishop PC; Parker JW; Turner RR; Fitzgibbons PL
    Am J Surg Pathol; 1988 Dec; 12(12):954-60. PubMed ID: 3202248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Flow cytometric DNA analysis of pediatric solid tumor].
    Taniguchi K; Hamazaki M
    Rinsho Byori; 1990 Sep; 38(9):1059-66. PubMed ID: 2172599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA and RNA content analysis by flow cytometry in the pathobiologic assessment of bone tumors.
    el-Naggar AK; Hurr K; Tu ZN; Teague K; Raymond KA; Ayala AG; Murray J
    Cytometry; 1995 Mar; 19(3):256-62. PubMed ID: 7736870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of DNA content in epithelial ovarian cancer.
    Gajewski WH; Fuller AF; Pastel-Ley C; Flotte TJ; Bell DA
    Gynecol Oncol; 1994 Apr; 53(1):5-12. PubMed ID: 8175021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytogenical analysis of brain tumors by FISH (fluorescence in situ hybridization) and FCM (flow cytometry).
    Kasai H; Kawamoto K
    Noshuyo Byori; 1995 Mar; 12(1):75-82. PubMed ID: 7795734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proliferative activity and aneuploidy in pleomorphic adenomas of the salivary glands.
    Martin AR; Mantravadi J; Kotylo PK; Mullins R; Walker S; Roth LM
    Arch Pathol Lab Med; 1994 Mar; 118(3):252-9. PubMed ID: 7907855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flow cytometric DNA analysis of pediatric intracranial ependymomas.
    Kotylo PK; Robertson PB; Fineberg NS; Azzarelli B; Jakacki R
    Arch Pathol Lab Med; 1997 Dec; 121(12):1255-8. PubMed ID: 9431314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatocyte growth factor is associated with poor prognosis of malignant gliomas and is a predictor for recurrence of meningioma.
    Arrieta O; Garcia E; Guevara P; Garcia-Navarrete R; Ondarza R; Rembao D; Sotelo J
    Cancer; 2002 Jun; 94(12):3210-8. PubMed ID: 12115353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Studies on nuclear DNA content in testicular germ cell tumors using flow cytometry].
    Kashiwagi A
    Hokkaido Igaku Zasshi; 1992 Nov; 67(6):801-14. PubMed ID: 1336479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.